Research Article
Systemic Analyses of the Expression of TPI1 and Its Associations with Tumor Microenvironment in Lung Adenocarcinoma and Squamous Cell Carcinoma
Table 1
Baseline clinicopathological characteristics stratified by the expression of TPI1 in lung adenocarcinoma and lung squamous cell carcinoma.
| | TCGA LUAD cohort | TCGA LUSC cohort | | TPI1 low | TPI1 high | value | TPI1 low | TPI high | value |
| | Age | | | 0.045 | | | 0.038 | | Gender | | | 0.021 | | | 0.098 | | Female | 151 (59.2) | 125 (49.0) | | 71 (29.1) | 55 (22.5) | | | Male | 104 (40.8) | 130 (51.0) | | 173 (70.9) | 189 (77.5) | | | Stage | | | <0.001 | | | 0.680 | | Stage I | 161 (63.4) | 114 (44.7) | | 121 (49.6) | 121 (49.6) | | | Stage II | 48 (18.9) | 77 (30.2) | | 83 (34) | 72 (29.5) | | | Stage III | 36 (14.2) | 47 (18.4) | | 35 (14.3) | 49 (20.1) | | | Stage IV | 9 (3.5) | 17 (6.7) | | 5 (2) | 2 (0.8) | | | Smoking status | | | 0.934 | | | 0.542 | | Nonsmoker | 39 (15.9) | 35 (14.2) | | 10 (4.3) | 8 (3.4) | | | Current smoker | 46 (18.8) | 73 (29.6) | | 61 (26) | 70 (29.5) | | | Reformed smoker (>15 years) | 85 (34.7) | 49 (19.8) | | 40 (17) | 41 (17.3) | | | Reformed smoker (≤15 years) | 75 (30.6) | 90 (36.4) | | 124 (52.8) | 118 (49.8) | |
|
|
Samples with missing value were excluded from the comparison in each analysis. |
